Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Agreement to Deliver Critical Medicines  ITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd. ("Sinopharm Hubei"), a subsidiary of Sinopharm Group. The Agreement, valued at approximately RMB ...